Journal of Pioneering Medical Science · مجلد 15 (03) · 189-194
Background: Bariatric surgery is an effective treatment for morbid obesity and its associated comorbidities. However, due to altered gastrointestinal anatomy and physiology, patients are at risk of developing nutritional deficiencies, which may impair long-term health and quality of life. Identifying the prevalence of such deficiencies is essential to guide appropriate follow-up and supplementation strategies. Objective: To determine the prevalence of nutritional deficiencies among patients who underwent bariatric surgery and to compare outcomes between sleeve gastrectomy and gastric bypass. Methodology: This cross-sectional analytical study included 365 patients who had undergone bariatric surgery. Adult patients aged 18-65 years with at least six months of postoperative follow-up were enrolled, while those with prior gastrointestinal surgery, chronic systemic illnesses or incomplete records were excluded. Data were collected on demographics, surgical procedure type and laboratory investigations including hemoglobin, ferritin, vitamin B12, folate, calcium and vitamin D. Standardized cut-off values were used to define deficiencies. Statistical analysis was performed using SPSS version 26, with results expressed as Mean±Standard deviation for continuous variables and frequencies and percentages for categorical variables. Comparisons between groups were made using Chi-square test, with p<0.05 considered significant. Results: Of 365 patients, 208 (57.0%) underwent sleeve gastrectomy and 157 (43.0%) gastric bypass. The mean age was 40.9±10.1 years and 220 (60.3%) were female. The most common deficiency was vitamin D, present in 202 patients (55.3%), followed by iron deficiency in 146 (40.0%) and anemia in 142 (38.9%). Vitamin B12 deficiency was observed in 110 (30.1%), folate in 81 (22.2%) and calcium in 76 (20.8%). Multiple deficiencies were noted in 134 patients (36.7%). Deficiencies were significantly more frequent in gastric bypass compared to sleeve gastrectomy for vitamin D (62.4% vs. 50.0%, p = 0.02) and iron (45.9% vs. 35.6%, p = 0.03). Women were more likely to have anemia (45.9% vs. 28.3%, p = 0.001) and vitamin D deficiency (60.5 vs. 47.6%, p = 0.01). The prevalence of deficiencies increased with time since surgery, with the highest rates observed beyond two years. Conclusion: Nutritional deficiencies are common after bariatric surgery, particularly vitamin D and iron deficiency and are more prevalent following gastric bypass than sleeve gastrectomy. Women and patients with longer follow-up durations are at greater risk. These findings underscore the need for structured postoperative monitoring, lifelong supplementation and patient education to prevent long-term health complications.
bariatric surgerynutritional deficiencyvitamin D deficiencyiron deficiency
Ecology and Evolution · مجلد 16 (8) · e74039-e74039
ABSTRACT Hepatozoon canis is the causative agent of canine hepatozoonosis that results in lethargy and severe anemia during acute infection in dogs. In this investigation, 654 blood samples were collected from apparently healthy dogs in Punjab and Khyber Pakhtunkhwa (KPK) provinces in Pakistan and screened for the presence of H. canis . Phylogenetic diversity of the detected H. canis DNA, infection‐associated risk factors and parasite‐induced alterations in the host's complete blood count were also evaluated. PCR‐based screening confirmed the H. canis infection in 48 out of 654 (7.3%) dog blood samples. The presence of this apicomplexan protozoa was confirmed through Sanger sequencing. Phylogenetic reconstruction using the H. canis 18S rRNA gene showed that the sequences generated in this study clustered closely with isolates previously reported from India, Australia, Iran, Zambia, China, Spain, and Brazil. The risk factor assessment indicated that parasite prevalence differed significantly between the sampling sites but did not vary between the dog breeds, animal sex, and the presence or lack of ecto‐parasitic infestation in dogs. Reduced hematocrit levels were recorded in H. canis infected dogs. In conclusion, H. canis was prevalent among the dogs in surveyed regions of Pakistan, with infection rates varying significantly among sampling districts. Furthermore, infected dogs exhibited reduced hematocrit levels, suggesting that H. canis infection may contribute to hematological alterations even in apparently healthy animals.
Introduction Although diabetes mellitus (DM) is a leading cause of cardiovascular complications, few studies have evaluated the epidemiology of these complications in primary care in Bahrain. Since data from primary care settings are particularly important, as most patients with diabetes are managed in this setting, this study aimed to determine the prevalence and predictors of diabetic complications among patients attending primary healthcare centers in Bahrain. Methods A cross-sectional study was conducted among adult patients with DM attending diabetic clinics in primary care centers across Bahrain. Demographic, clinical, and laboratory data, and diabetes complications were collected. Microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (stroke, acute coronary syndrome, peripheral arterial disease) complications were assessed. Descriptive and inferential analyses were performed. Results A total of 585 patients were enrolled, with a median age of 61±14 years. Most patients were males (n=326, 55.7%), had type 2 DM (n=566, 96.8%), and had uncontrolled diabetes (n=349, 59.7%). Approximately half of the patients (51.6%) had at least one diabetes-related complication. Neuropathy (n=158, 27.0%) and retinopathy (n=89, 15.2%) were the most frequent microvascular complications, while peripheral vascular disease (n=64, 10.9%) and ischemic heart disease (n=61, 10.4%) were the leading macrovascular complications. Multivariable analysis revealed that higher total cholesterol (OR=1.326, p=0.031) and lower estimated glomerular filtration rate, eGFR (OR=1.009, p=0.025) predicted macrovascular complications. Diabetic foot ulcers increased macrovascular complications by 14-fold (p<0.001). Predictors of microvascular complications included type 2 DM (OR=16.277, p=0.011), longer DM duration (OR=1.156, p<0.001), higher triglycerides (OR=1.222, p=0.045), dyslipidemia (p=0.036), and foot ulcers (27-fold; p=0.002). Conclusion Diabetic complications were prevalent among diabetic patients in Bahrain, especially those with impaired renal function, dyslipidemia, anemia, and foot ulcers. Early identification and management of these comorbidities is crucial to prevent diabetes-related complications.
Fox-Fordyce disease (FFD) is a rare, chronic skin disorder affecting apocrine sweat glands, predominantly in women. It manifests as pruritic, dome-shaped papules in areas such as the axillae and pubic region. Treatment remains challenging, with limited success from conventional therapies. We report two cases of Saudi women aged 27 and 28 years presenting with hyperpigmented axillary papules and mild pruritus, consistent with FFD. One patient had no comorbidities, while the other had a known history of sickle cell anemia. Both cases were managed with laser therapy (erbium:yttrium aluminum garnet (YAG) in case 1 and ablative CO₂ in case 2) using precise protocols and follow-up plans. Clinical images demonstrated visual improvement post treatment. Adjunctive topical therapy was administered to manage inflammation and prevent hyperpigmentation. The cases underscore the typical presentation of FFD and the potential efficacy of laser-based interventions, even in patients with complex medical histories. Notably, the presence of sickle cell anemia did not exacerbate FFD manifestations, supporting the current treatment modalities. While hormonal therapy was not employed, its relevance remains a subject for future exploration. Laser therapy offers a promising approach for managing refractory FFD. Further studies are warranted to evaluate long-term outcomes and explore hormone-modulating strategies tailored to FFD's pathophysiology.
Toxicology Research · مجلد 13 (2) · tfae066-tfae066
Abstract Because of their beneficial properties, natural products, especially medicinal plants, are becoming increasingly popular worldwide and play a significant role in research. This study was aimed to evaluate the nephroprotective effect of sinapic acid against mercuric chloride-induced renal toxicity in mice. The mice were allocated to four groups named a normal group (G1), model group (G2; received HgCl2, 1 mg/kg bw), treatments groups (G3 and G4: received 50 and 100 mg/kg bw of sinapic acid together with HgCl2). Mice received HgCl2 remarkably showed alteration in all examined biochemical biomarkers (urea, creatinine, and bilirubin), and induced alteration in blood cell picture and anemia. HgCl2 intoxication decreased both systemic and renal antioxidant activity and induced over all oxidative stress as indicated by alteration in inflammation and oxidative stress associated markers. HgCl2 affected renal histology with leukocytic and inflammatory cell infiltration, fibrosis and tubular necrosis. Administration of sinapic acid (50 and 100 mg/kg bw) markedly restored the HgCl2−induced oxidative stress (serum and renal: MDA, GSH, CAT, SOD, and T-AOC), proinflammatory cytokines (serum and renal: TNF-α, IL-6, IL-1β, and PGE2) and restored the changes on biochemical markers, and hematological parameters (hemoglobin, erythrocytes, platelets, and leukocytes). Taken together, the results of the present study disclose that sinapic acid has the potential to attenuate HgCl2-induced renal toxicity and may be an ideal choice against mercury poisoning.
Background Sickle cell disease (SCD) represents a group of inherited health conditions that affect red blood cells. SCD is a relatively common genetic disorder in Saudi Arabia, with the highest prevalence found in the Eastern Province region. The most common complications of SCD include acute chest syndrome, vaso-occlusive crisis, stroke, and avascular necrosis of the femoral head. The disease itself is not a cause of mortality but systemic complications are. Methodology In this retrospective study, we aimed to determine the frequency of painful crisis and the associated complications of sickle cell anemia (SCA) among children at King Saud Medical City (KSMC) in Riyadh, Saudi Arabia. Results This study included a total of 70 children with SCA below the age of 14 years who were admitted to KSMC from January 2021 to December 2021. Overall, 60% of the participants had one painful crisis attack per year, whereas 27% had two attacks. Furthermore, 94% of the participants were being treated with hydroxyurea. The most frequent cause of admission was painful crises with acute chest syndrome. Conclusions This study highlights the frequency of hydroxyurea use among SCA patients. Our results showed that participants who developed one to two painful crises per year were hospitalized for four to nine days on average with increased utilization of hydroxyurea.
International Journal of Clinical Medical Research · مجلد 1 (1) · 28-35
Background: The objective of this study was to compare the cost of outpatient ferric carboxymaltose (FCM; Ferinject®) versus Iron sucrose complex (ISC; Ferosac®), two prevalent intravenous iron therapy used in the treatment of iron-deficiency anemia (IDA) in the Kingdom of Saudi Arabia (KSA) from a tertiary care hospital perspective. Methods: A retrospective study was performed for all patients who were administered FCM in the outpatient clinical setting at Prince Sultan Military Medical City from January 1, 2019, until December 31, 2019. The descriptive data was analyzed using Microsoft Excel 2019 (Microsoft Corporation, Redmond, WA, USA). The total cost of treatment reflected the cost of drugs, the cost of disposables for each infusion, drug monitoring costs during infusion, the cost of productivity loss, and patient traveling cost. Result: Overall, 993 patients with IDA, treated with FCM in 1,688 outpatient visits were recruited in the study. In the outpatient setting, the per annum cost of treatment was SAR 1,434,092.50 with FCM treatment and SAR 1,715,299.70 with ISC treatment, with a corresponding saving of 16.4% (SAR 281,207.20) with FCM. The cost savings with FCM treatment can be attributed to the reduced frequency of patient visits and corresponding reduction in drug monitoring costs (SAR 266,995.20;77.3%), loss of productivity per year (SAR 163,550.20; 77.3%), and cost of transportation per year (SAR 573,920.00; 77.3%). Conclusion: The use of FCM, as opposed to ISC resulted in a reduced number of iron infusions (4.4 visits for ISC as compared to one visit for FCM), accompanied by a reduction in the total cost. FCM may represent a cost-saving option compared with the existing alternative therapy used for the management of IDA in KSA.
ABSTRACT: Despite the availability and advancement of diagnostic and treatments with demonstrated benefits in minimizing cardiovascular morbidity and mortality, hypertension control rates remain suboptimal. Therefore, this research aimed to determine the prevalence of uncontrolled BP in rheumatoid arthritis (RA) patients and understand all potential risk factors for uncontrolled BP.We conducted a cross-sectional study on RA patients in 2 rheumatology clinics in 2 public hospitals in Riyadh. Patients' information such as demographics, comorbidities, drug use, and other clinical data were captured through a review of medical records and supplemented by patient interviews. Multivariate logistic regression was utilized for the analysis to identify the significant factors of uncontrolled BP (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg).In total, 834 subjects with RA and concomitant BP were involved in this cross-sectional study. The prevalence of uncontrolled BP was found to be 31.65% among all the study population. Multivariate analysis showed that males, subjects above 60 years of age, and smokers had a distinctly higher occurrence of uncontrolled BP. Among the patients with comorbid conditions, those with obesity, hyperlipidemia, diabetes, anemia, cancer, and reflex or gastroesophageal reflux disease also showed a significantly higher risk of uncontrolled BP (P < .05).The rate of uncontrolled BP was found to be alarmingly high in the study population. Age, gender, smoking, diabetes, obesity, hyperlipidemia, cancer, gastroesophageal reflux disease, and osteoporosis are independently linked with lack of BP control.
In several parts of the world, Boswellia sacra Fluck. is one of the most commonly used herbs for the treatment of arthritis. Its usage should be validated in light of recent findings of haematotoxicity. This study was aimed to determine the effect of chronic administration of standardized methanolic extract of frankincense on blood cell count in experimental animals. Using high-performance liquid chromatography, the active constituents of B. sacra extract; boswellic acids were analyzed. The effect of three different doses of the extract (250, 500, and 1000 mg/kg) on different blood cells and associated parameters was investigated. The behavior, food, and water consumption of the rats were recorded. Boswellic acids were present in varying amounts with α-boswellic acid and β-boswellic acid present in more amounts compared to other boswellic acids in the extract. All three doses tested had no effect on the animals’ behavior, food consumption, or weight gain. The administration of a low (500 mg/kg) and high (1000 mg/kg) dose of the extract resulted in a non-dose dependent reduction in MCH ( p < 0.01 and p < 0.05, respectively), but no other blood parameters were significantly affected. The B. sacra extract produces hypochromic normocytic anemia in rats at higher doses of 500 and 1000 mg/kg and this effect was not dose-dependent.
Journal of King Saud University - Science · مجلد 33 (8) · 101601-101601
As intestinal failure (IF) inhibits the digestive system from absorbing nutrients, total parenteral nutrition (TPN) is required to provide all of a person's nutritional demands. In children with malabsorptive conditions like IF, iron deficiency anemia (IDA) is common. This study used a quasi-experimental approach to assess the efficacy and safety of oral iron therapy in treating IDA in TPN-dependent children with IF. Sixteen pediatric patients with an ongoing history of IF, TPN dependency, and iron deficiency anemia were enrolled and given an oral iron syrup dose of ferric hydroxide polymaltose complex (6 mg/kg/day in 2–3 separate doses of elemental iron) after receiving ethical approval and parental consent. Blood tests were done to measure serum iron, ferritin, complete iron-binding capacity [TIBC], transferrin saturation [TSAT], and hemoglobin (Hb) level at the time of inclusion (T0), 14 (T14), and 30 days after treatment (T30). The mean age was 7.13 (±1.99) and female were 12 (75%). No remarkable change in Hb level was noted in the first and second subsequent follow-ups, notwithstanding, the normal estimation of the serum ferritin level significantly increased during the first follow-up (on fourteenth day) which further enhanced by second follow-up (30th day). The aggregate of the total iron binding capacity (TIBC) declined during the course of oral iron therapy with a reduction in transferrin saturation. The data suggest that oral iron therapy is unsuccessful in the treatment of IDA in children with IF. There is no substantial improvement in hemoglobin level or iron profile aside from serum ferritin. In order to avoid using parenteral iron in IF patients, an additional supportive system is needed to aid in the integration of oral iron therapy.
oral iron supplementationiron deficiency anemiaintestinal failuretotal parenteral nutrition
Journal of Family Medicine and Primary Care · مجلد 9 (6) · 2720-2720
Background: Hearing loss is a common disability affecting nearly 360 million people in the world and 75% of cases live in developing countries. Many children are vulnerable to diseases causing hearing loss that often go untreated. The aim of this study is to identify the possible etiological factors and clinical presentations of children who presented with hearing loss at the Khartoum Teaching Hospital. Materials and Methods: a descriptive, cross-sectional hospital-based study. A total of 100 (response rate of 94%) children aged 5–15 who presented with hearing loss at Khartoum Teaching Hospital were included in this study. A detailed structured, pretested, and pre-coded questionnaire was used. After data collection, hearing examination was performed by an E.N.T specialist, then audiometry performed to diagnose hearing loss and for classification of the hearing loss type. Discriptive Statisistics frequencies and cross-tabulation were done. A Chi-square test was used for proportions. A P value of less than 0.05 considered significant. Results: Out of 100 patients, 68 patients (68%) belonged to the 5–10 years age group. The mean age was 8.5 years. The male to female ratio was 1.00–1.13. Conductive hearing loss was found in 66% of the studied group, sensory-neural hearing loss in 23% and the mixed type in 11%. Regarding the etiology, otitis media was found in 41 of patients (41%), congenital hearing loss in 22% (22 patients), traumatic hearing loss in 4%, sickle cell anemia in 2%, mumps in 14%, diabetes mellitus in 3%, and measles in 8% of the patients. In conclusion, a number of preventable causes were shown to contribute significantly to the etiology of hearing loss. Conclusion: The commonest factors associated with hearing loss among participants were otitis media and hereditary causes, respectively. Further community-based studies of hearing-impaired children are necessary for planning effective preventive and curative programs.
childhood hearing lossconductive hearing losssensorineural hearing lossotitis media
The Egyptian Journal of Hospital Medicine · مجلد 72 (6) · 4625-4629
Objectives: To assess the prevalence of iron deficient anemia (IDA) within Saudi Arabian females and to examine the risk factors leading to the IDA. Methods: A cross-sectional study on 683 healthy females aged between 18 and 40 years was performed within April 2016. Data on the participants’ socio-demographics, diet, health, anthropometry, and hematological and biochemical iron status indices were gathered. Univariate and multivariate logistic regression analysis were used in order to reveal the IDA risk factors. Results: A total of 683 non-pregnant women aged between 18-40 years were included in the analysis. The prevalence of IDA was 41.6%. In the multivariate regression analysis; inadequate iron and vitamin C intakes, infrequent (≤2 times per week) consumption of red meat and fish, menstruation disorder eg: (Twice or more per month), (more than 8 days), (blood clotting and heavy blood flow),blood disorder and previous blood transfusion, past personal history of IDA and familial history of IDA were significantly associated with increased odds of IDA. Conclusion: To reduce IDA in Saudi Arabian women, the country needs a multifaceted approach that incorporates iron supplementation, food fortification, rich dietary iron sources and by raising awareness of the food and drinks which facilitate or hinder the bioavailability of iron.
iron deficiency anemiaprevalencerisk factorswomen of reproductive age
Abstract Introduction: Fanconi Anemia (FA) is an autosomal recessive disorder characterized by bone marrow failure (BMF), constitutional anomalies and high risk of developing cancer. Distinguishing FA from severe aplastic anemia (SAA) can be challenging especially in asyndromic patients. We undertook a clinical and laboratory cohort study of adolescent and young adult (AYA) patients with a diagnosis of FA treated at our institution to characterize the clinical features in our population, and conducted a prospective translational study to explore integration of a genomic and proteomic approach for improved diagnosis and molecular characterization of FA. Methods: Data on FA patients was obtained from an institutionally approved BMF database and hematopoietic stem cell transplant (HSCT) database. Further data was obtained from a register of chromosomal breakage (CB) analysis results. Index cases were identified if they were older than 14 years of age at the time of diagnosis or under the care of adult hematology with a clinical diagnosis of FA based on the presence of BMF and abnormal CB, or clinical phenotype with the presence of homozygous FA related genes. Family pedigrees were constructed based on history. In addition, patients presenting with BMF were enrolled onto an institutionally approved study investigating proteomic biomarkers and genomics of BMF syndromes. Consented peripheral blood samples and/or extracted DNA were subject to either panel based next generation sequencing (NGS) testing as part of the Saudi Genome Project or subjected to whole exome sequencing (WES) by external lab. For proteomic analysis, peripheral blood plasma (PBP) samples from 6 patients with FA, 10 SAA patients and 7 normal controls were subjected to expression proteomics using liquid chromatography tandem mass spectrometry (LC-MS/MS). Result: Patients and clinical features: 55 patients (26 M, 29 F) in 30 families were identified. While 18 patients (32%) were referred with a diagnosis/suspicion of FA, in 26 (47%) FA was diagnosed at our institution. The most frequent anomaly was short stature (14 patients, 25%), skin changes (7, 12%), urogenital abnormalities (7, 12%), dysmorphism/craniofacial abnormalities (7, 12%), hands anomalies (4, 7%); 12 (22%) had no recorded anomalies. 18 patients (33%) developed a malignancy either before or after diagnosis of FA: solid tumors in 5 (9%), AML and/or MDS in 15 (27%); 3 (5%) of these patients had both solid tumors and AML/MDS. Diagnostic Tests: 35 patients (63.6%) had a positive CB analysis with diepoxybutane (DEB) or mitomycin-C (MMC) testing; in 5 patients (9%) DEB testing was borderline and 3 (5%) had a normal CBA but had a diagnostic phenotype+/- family history and presence of a homozygous mutation in a known FA related gene. 14 patients had cytogenetic abnormalities and abnormalities involving chromosome 1 were the most frequent (50%). Mutation Analysis: Mutational analysis was available for 12 (22%) cases; homozygous mutations in FA genes were identified in 10 patients (18%) in 7 families (23% of families): FANCA (5 patients/3 families); BRIP1 (2/2); FANCP (1/1); FANCD2 (2/1). In one case, post matched sibling (HSCT) blood sample revealed a known pathogenic heterozygous c.2632G>C,p.Glu878Gln mutation in FANCA, suggesting a carrier donor. Proteomic analysis: Over 1650 unique PBP protein species were identified of which 605 were significantly differentially expressed (≥ 2 to ∞ - fold change & p < 0.001) between SAA /FA/ normal control subjects (Fig 1a). DNMT3A, Kinase Insert Domain Receptor (KDR) and TGFB-1 was found to be highly expressed in SAA versus FA, while ATM and APOB were highly expressed in FA versus SAA (Fig.1b). Treatment outcomes: 36 out of 55 patients (65%) received HSCT. Actuarial survival of HSCT (n=37) and non-HSCT (n=14) patients was 70% and 77%, respectively. Treatment details were not available on 6 (11%). CONCLUSION: We report the first characterization of AYA patients with FA in Saudi Arabia. Our report emphasizes the need for a high index of suspicion of a diagnosis of FA in BMFs. CB may be falsely negative in cases, and panel based and/or WES based NGS testing increases diagnostic accuracy; in this cohort, mutations in FANCA were the most frequent (50%). Occurrence of hematological and solid tumors is a significant risk in these AYA patients. We also report proteomic panels as potential biomarkers that distinguish FA from SAA and may provide mechanistic insights. Disclosures No relevant conflicts of interest to declare.
Fanconi anemiabone marrow failureadolescent and young adult patientssevere aplastic anemia